Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 2289-a, 2002;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flourié, F.
Right arrow Articles by Alcaraz-Galvain, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Flourié, F.
Right arrow Articles by Alcaraz-Galvain, D.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2002;48:2289.)
© 2002 American Association for Clinical Chemistry, Inc.


Letters

Falsely Increased Thyroid-stimulating Hormone Concentrations attributable to Interference from Human Anti-mouse Antibodies

Françoise Flourié1a, François Parant1, Marie Christine Pénès1 and Dany Alcaraz-Galvain2

1 Laboratoire de Biochimie, Hôpital Edouard Herriot, 5, Place d’Arsonval, Lyon 69437, France

2 Service de Techníques, Nucléaires et Biophysiques, Centre Hospitalier Lyon Sud, Pierre-Bénite 69495, France

aAuthor for correspondence. Fax 33-4-7211-0597.


To the Editor:

We describe a case of a spurious increase in serum thyroid-stimulating hormone (TSH) attributed to a circulating human anti-mouse antibody (HAMA) in a two-site mouse monoclonal antibody-based assay.

A 71-year-old woman on long-term levothyroxine therapy was referred for investigation of uveitis. Her serum TSH had been maintained within the usual reference interval for more than a decade. The initial TSH value by an immunometric method (assay A) on the Dimension RxL analyzer (Dade Behring) was 7.5 mIU/L (reference interval, 0.34–4.82 mIU/L). Because of this unexpected result, it was checked by another method (assay B), a two-site chemiluminescent immunometric assay (Third Generation TSH on the Immulite 2000; DPC Corp.). The TSH value for the same serum was 0.36 mIU/L (reference interval, 0.25–4.60 mIU/L), and free thyroxine was 18.8 pmol/L (reference interval, 10.3–25.5 pmol/L).

In assay A, chromium dioxide particles are coated with mouse monoclonal antibodies specific for the intact TSH, and detection is by an alkaline phosphatase-labeled mouse F(ab')2 fragment specific for the TSH subunit. In assay B, the first mouse monoclonal antibodies specific for TSH are bound to a polystyrene bead, and detection is by an alkaline phosphatase-labeled goat polyclonal antibody preparation.

After addition of a blocking reagent composed of binders to inactivate heterophilic antibodies (HBT; Scantibodies Inc.), serum TSH on the Dimension RxL was 0.49 mIU/L. HAMA (IgG) measured by ELISA (Medac Diagnostika) was 253 µg/L (reference values, <40 µg/L).

In two-site (sandwich) immunoassays, HAMA present in serum can interfere by bridging between the mouse immunoglobulin capture antibody and the mouse immunoglobulin conjugate (1). The use of F(ab')2 fragment eliminates the interference of anti-FC region heterophilic antibodies, but the interference of anti-idiotypic antibodies remains. Interference by HAMA or by an antibody with HAMA activity has been described previously with TSH assays from other manufacturers (2)(3)(4). This is the first description of such interference in TSH measurements on the Dimension RxL. Several authors have proposed the addition of nonspecific animal immunoglobulins from the same species or from other species to prevent binding with HAMAs (5)(6). We understand that assay A has been reformulated with bovine gamma globulins. We retested the sample with the reformulated assay and obtained a value within the reference interval (0.34 mIU/L). We conclude that the presence of heterophilic antibodies should be considered when measured TSH concentrations are not compatible with either the clinical history or other thyroid functions tests.


Footnotes

Editor’s Note: The manufacturer declined to comment.


References

  1. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942-956.[Abstract/Free Full Text]
  2. Covinsky M, Laterza O, Pfeifer JD, Farkas-Szallasi T, Scott MG. An IgM {lambda} antibody to Escherichia coli produces false-positive results in multiple immunometric assays. Clin Chem 2000;46:1157-1161.[Abstract/Free Full Text]
  3. Frost SJ, Hine KR, Firth GB, Wheatley T. Falsely lowered FT4 and raised TSH concentrations in a patient with hyperthyroidism and human antimouse monoclonal antibodies. Ann Clin Biochem 1998;35:317-320.
  4. Wood JM, Gordon DL, Rudinger AN, Brooks MD. Artifactual elevation of thyroid-stimulating hormone. Am J Med 1991;90:261-262.[ISI][Medline] [Order article via Infotrieve]
  5. Boscato LM, Stuart MC. Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1998;34:27-33.[Abstract/Free Full Text]
  6. Vaidya HC, Beatty BG. Eliminating interferences from heterophilic antibodies in a two-site immunoassay for creatine kinase MB by using F(ab')2 conjugate and polyclonal mouse IgG. Clin Chem 1992;38:1737-1742.[Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
R. Sapin, A. Agin, and F. Gasser
Misleading High Thyrotropin Results Obtained with a Two-Site Immunometric Assay Involving a Chimeric Antibody
Clin. Chem., May 1, 2004; 50(5): 946 - 948.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flourié, F.
Right arrow Articles by Alcaraz-Galvain, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Flourié, F.
Right arrow Articles by Alcaraz-Galvain, D.
Related Collections
Right arrow Endocrinology and Metabolism


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS